Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.48 |
| ▸ | TSHR | P16473 | 4/20 | 0.45 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | INMT | O95050 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | PKM | P14618 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL31290083 | 0.90 | KMT2A (0.53) | KMT2ATSHRPIK3CDHTTPOLB | |
| Methacrylic Acid SCHEMBL18270983 | 0.87 | KMT2A (0.50) | KMT2ATSHRPIK3CDHTTPOLB | |
| SCHEMBL1817231 | 0.85 | KMT2A (0.47) | KMT2ATSHRPIK3CDPOLBMEN1 | |
| SCHEMBL39045 | 0.84 | — | — | |
| Methacrylic Acid SCHEMBL28238503 | 0.83 | INMT (0.53) | KMT2ATSHRPIK3CDHTTPOLB | |
| SCHEMBL819041 | 0.82 | TSHR (0.52) | KMT2ATSHRPIK3CDHTTMEN1 | |
| Water SCHEMBL9676194 | 0.82 | TSHR (0.52) | KMT2ATSHRPIK3CDHTTMEN1 | |
| Arsenic SCHEMBL28233851 | 0.82 | TSHR (0.52) | KMT2ATSHRPIK3CDHTTMEN1 | |
| Ammonia Solution, Strong SCHEMBL29940029 | 0.82 | TSHR (0.52) | KMT2ATSHRPIK3CDHTTMEN1 | |
| Acrylic Acid SCHEMBL23853052 | 0.82 | TSHR (0.46) | KMT2ATSHRPIK3CDHTTPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 76 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11912831-B2 | Hydroxyethylpyrrolidone ethacrylate/glycidyl ethacrylate copolymers | ISP INVESTMENTS LLC (US) | 2024-02-27 | — | — | US | claimed |
| US-11396000-B2 | Friable shell microcapsules, process for preparing the same and method of use thereof | ISP INVESTMENTS LLC (US) | 2022-07-26 | — | — | US | claimed |
| EP-3884963-A1 | NAPROXEN/DEXAMETHASONE-BASED NANOPARTICLES | Consejo Superior de Investigaciones Científicas (CSIC) (ES) | 2021-09-29 | — | — | EP | claimed |
| EP-3377546-B1 | PROCESS FOR THE PREPARATION OF HYDROXYETHYLPYRROLIDONE METHACRYLATE/GLYCIDYL METHACRYLATE COPOLYMERS | ISP INVESTMENTS LLC (US) | 2020-10-21 | — | — | EP | claimed |
| US-10274852-B2 | Coating compositions for forming toner coatings | ISP INVESTMENTS LLC (US) | 2019-04-30 | — | — | US | claimed |
| US-20180346627-A1 | HYDROXYETHYLPYRROLIDONE METHACRYLATE/GLYCIDYL METHACRYLATE COPOLYMERS | ISP INVESTMENTS LLC (US) | 2018-12-06 | — | — | US | claimed |
| US-20180346628-A1 | POLYMERS FOR ORAL CARE COMPOSITIONS | ISP INVESTMENTS LLC (US) | 2018-12-06 | — | — | US | claimed |
| US-20180327628-A1 | COATING COMPOSITIONS FOR FORMING TONER COATINGS | ISP INVESTMENTS LLC (US) | 2018-11-15 | — | — | US | claimed |
| WO-2018106666-A1 | ORAL CARE COPOLYMERS AND COMPOSITIONS AND METHODS FOR USE | ISP INVESTMENTS LLC (US) | 2018-06-14 | — | — | WO | claimed |
| US-9821589-B2 | Coating compositions for forming toner receptive coatings | ISP INVESTMENTS LLC (US) | 2017-11-21 | — | — | US | claimed |
| US-20160282737-A1 | COATING COMPOSITIONS FOR FORMING TONER COATINGS | ISP INVESTMENTS INC. (US) | 2016-09-29 | — | — | US | claimed |
| US-20160059607-A1 | COATING COMPOSITIONS FOR FORMING TONER RECEPTIVE COATINGS | ISP INVESTMENTS INC. (US) | 2016-03-03 | — | — | US | claimed |
| US-20160053131-A1 | COATING COMPOSITIONS FOR FORMING TONER COATINGS | ISP INVESTMENTS INC. (US) | 2016-02-25 | — | — | US | claimed |
| WO-2014160631-A1 | COATING COMPOSITIONS FOR FORMING TONER COATINGS | ISP INVESTMENTS INC. (US) | 2014-10-02 | — | — | WO | claimed |
| WO-2014160604-A1 | COATING COMPOSITIONS FOR FORMING TONER COATINGS | ISP INVESTMENTS INC. (US) | 2014-10-02 | — | — | WO | claimed |
| WO-2014160672-A1 | COATING COMPOSITIONS FOR FORMING TONER RECEPTIVE COATINGS | ISP INVESTMENTS INC. (US) | 2014-10-02 | — | — | WO | claimed |
| EP-2106413-A1 | THERMALLY SENSITIVE POLYMERIC DYE TRANSFER INHIBITOR | BASF SE (DE) | 2009-10-07 | — | — | EP | claimed |
| WO-2008077910-A1 | THERMALLY SENSITIVE POLYMERIC DYE TRANSFER INHIBITOR | BASF SE (DE) | 2008-07-03 | — | — | WO | claimed |
| EP-3377549-B1 | PROLIFEROUS POLYMERS COMPRISING LACTAMIC MOIETIES | ISP INVESTMENTS LLC (US) | 2024-09-04 | — | — | EP | disclosed |
| US-20070123673-A1 | CATALYTIC PROCESS FOR PREPARING (METH)ACRYLATES FROM N-HYDROXYALKYLATED LACTAMS | BASF AKTIENGESELLSCHAFT (DE) | 2007-05-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180346628-A1 | POLYMERS FOR ORAL CARE COMPOSITIONS | MPO, SMARCC1, PTMA | KMT2A 826/4885TSHR 4236/4885PIK3CD 3045/4885 |
| US-11912831-B2 | Hydroxyethylpyrrolidone ethacrylate/glycidyl ethacrylate copolymers | MMAB, PCNA, HMBS | KMT2A 1105/4885TSHR 4725/4885PIK3CD 3086/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.